Home > Applications > Microbial + Metagenomics
Microbial + Metagenomics
'Shotgun' - no longer the weapon of choice
Implement the next-level of technology to help unravel the complexity of the microbiome+
Microbial and metagenomic testing involves analysing the genetic material of microorganisms present in a sample, such as a bodily fluid, tissue, or environmental sample, without the need for culturing. This approach allows for the identification and characterization of a wide range of microbes, including bacteria, viruses, fungi, and parasites, as well as their genetic diversity and interactions within complex microbial communities.
Microbial testing is used in clinical settings to diagnose infectious diseases, monitor treatment efficacy, detect antimicrobial resistance, and investigate outbreaks. Metagenomic testing expands beyond targeted pathogens to provide a comprehensive view of the entire microbial community in a sample, enabling insights into the microbiome’s role in health and disease.In research and environmental monitoring, microbial and metagenomic testing help understand microbial ecology, study microbial diversity, track microbial contamination, and assess environmental health.
Decode Science can assist help improve your outcomes by working together on your entire workflow. From automation and sequencers, library prep and extraction kits, quality control and more. At Decode Science, we pride ourselves on the level of flexibility, customisation, and collaboration we bring when working together to come up with a solution that improves outcomes for you and your patients.
Twist Bioscience
Twist Bioscience, headquartered in South San Francisco, is a prominent biotechnology company specializing in the manufacture of synthetic DNA and DNA products for diverse industries. Established in 2013 by Emily Leproust, Bill Banyai, and Bill Peck, Twist Bioscience has quickly emerged as a leader in the field.
In March 2021, the company was represented by Emily Leproust at a tabletop exercise during the Munich Security Conference. The simulation focused on an outbreak of weaponized monkeypox, showcasing Twist Bioscience's involvement in addressing critical global challenges.
In May 2021, Twist Bioscience collaborated with the Genome Project-Write to launch a groundbreaking Computer-Aided Design (CAD) platform for whole genome design. This innovative platform automates workflows, facilitating collaborative efforts essential for scaling up genome design—from designing plasmids to megabases across entire genomes. This initiative marks a significant advancement in genomic research and underscores Twist Bioscience's commitment to driving progress through technology and collaboration.
LEARN MORE >
MGI
MGI, also known as MGI Tech, is a prominent Chinese biotechnology company specializing in a comprehensive array of products and technologies catering to the genetic sequencing, genotyping, gene expression, and proteomics markets. Headquartered in Shenzhen, China, MGI has established itself as a leading provider of innovative solutions to meet the evolving needs of the biotechnology and life sciences industries. With its diverse product line and cutting-edge technologies, MGI is dedicated to advancing research and applications in genomics and proteomics fields, contributing to scientific breakthroughs and advancements worldwide.
LEARN MORE >
STOmics
STOmics stands at the forefront of advancing spatially-resolved transcriptomic analysis through its revolutionary SpaTial Enhanced REsolution Omics-Sequencing (Stereo-seq) technology. Leveraging proprietary Stereo-seq technology, which is built on DNA Nanoball (DNB) technology, researchers gain access to a groundbreaking tool for exploring spatial biology with unparalleled field-of-view and resolution.
Stereo-seq operates in square-centimeter units, with the standard 1x1 cm RNA capture unit utilizing the STOmics-GeneExpression-S1 Chip. This innovative chip combines centimeter-scale field-of-view in situ capture of comprehensive transcriptome information with nanoscale resolution, resulting in unmatched quality of spatial transcriptomic analysis.
LEARN MORE >
seqWell
seqWell is on a mission to redefine NGS library preparation, unlocking the full potential of today's DNA sequencing instruments. At the heart of our innovation lies the plexWell™ platform, a groundbreaking library preparation technology that revolutionizes multiplexing by enabling simple and scalable processing of hundreds to thousands of samples without the need for time- and cost-consuming normalization steps.
The plexWell platform boasts a wide-ranging impact across various applications, including synthetic biology, targeted sequencing, single-cell analysis, and both low- and high-depth sequencing of human, plant, animal, and microbial genomes. By eliminating the complexities associated with traditional library preparation methods, plexWell empowers researchers to accelerate their sequencing workflows while maximizing throughput and efficiency.
LEARN MORE >
BiOptic
BiOptic, Inc. is a pioneering biotechnology instrument company dedicated to the development, manufacturing, and marketing of fully-integrated systems and tests for Fluorescence Immunoassay analysis across various sectors, including research, clinical, and industrial markets. The cutting-edge systems empower rapid and sophisticated Antibody-Antigen interaction testing, automating complex manual laboratory procedures for enhanced efficiency and accuracy.
The user-friendly systems seamlessly integrate multiple intricate and time-consuming steps, such as sample preparation and detection, streamlining the analysis of complex biological samples. Central to the technology are the proprietary pen-size gel-cartridges, which facilitate the efficient processing of samples within the systems.
LEARN MORE >
Let’s Find You an Application That Helps Your Research
Get a call from your local Decode Science representative to help you find the best fit genomics products for you.
- Or give us a call at:
- 1300 581 991